CountryOfPapers CountryOfPapers
Journal list Promote Sponsor
verified SJR 1,494 · Q1 • database DOAJ indexed
Molecular Therapy - Oncolytics
United Kingdom · Cell Press
workspace_premium Q1 — Molecular Medicine visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Molecular Therapy - Oncolytics

Molecular Therapy - Oncolytics is a journal indexed in SJR in Molecular Medicine and Oncology with an H index of 42. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 2880 €. The scope of the journal is focused on cell biology, oncolytics, molecular therapy, gene therapy, cancer. It has an SJR impact factor of 1,494 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,494.

Publisher: Cell Press
Category: Molecular Medicine
Indexation: verifiedDOAJ
open_in_new Portal NPD menu_book Author guidelines
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
1,494 Q1
H-index 42
Acceptance rate pie_chart
36%
Source Acceptance_Rate
Time to publication hourglass_top
6 weeks
Field Average_time_publication_weeks
Publication cost (APC) payments
2.880 € Open Access
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

DOAJ

SJR Impact

1,494

H-index

42

Docs (year)

97

Docs 3y

488

Total refs

5554

Cites 3y

2595

Citable 3y

478

Cites/Doc 2y

5.35

Ref/Doc

57.26

Immediate OA

2880 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs

What is the SJR of Molecular Therapy - Oncolytics?

Molecular Therapy - Oncolytics has an SJR of 1,494 (best quartile Q1) in the CountryOfPapers database.

What is the APC / publication cost?

Immediate OA APC is 2880 EUR.

What is the acceptance rate?

The acceptance rate recorded for Molecular Therapy - Oncolytics is 36%.